|
Prevestrus vet
|
50 mg/tabl.
|
EU/2/25/338/008
|
Vetcare Oy, Somija
|
-
|
dogs (bitches)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Finrozole
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
23-Apr-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/338/008 |
|
1 |
ABPE burka, 28 tablete |
-
|
|
|
DIVENCE PENTA
|
2 ml
|
EU/2/24/307/003
|
Laboratorios Hipra S.A., Spānija
|
QI02AH
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for emulsion for injection
|
| International name (active substance): |
Bovine viral diarrhoea virus 1, E2 protein, recombinant, Bovine viral diarrhoea virus 2, E2 protein, recombinant, Bovine herpesvirus 1, strain CEDDEL, gE- tk- double-gene deleted, Live, Bovine parainfluenza virus 3, strain SF-4, Inactivated, Bovine respiratory syncytial virus, strain Lym-56, Live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
09-Apr-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/307/003 |
2 ml |
1 |
Stikla flakons, 20 devas/flakonā |
-
|
|
|
Dexdomitor
|
0.5 mg/ml
|
EU/2/02/033/001
|
Orion Corporation, Somija
|
QN05CM18
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Dexmedetomidine hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Orion Corporation Fermion, Somija
|
| Date of authorisation/renewal: |
02-Aug-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/02/033/001 |
0,5 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
|
|
Lotilaner/Milbemycin Elanco 450 mg/16,88 mg
|
-
|
EU/2/26/361/016
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
25-Feb-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/361/016 |
|
18 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Advocate Spot-on šķīdums vidējiem suņiem
|
-
|
EU/2/03/039/046
|
Bayer Animal Health , Vācija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
16-Jul-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/046 |
|
12 |
Pipete, 1 ml |
-
|
|
|
Purevax RC
|
-
|
EU/2/04/051/001
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI06AH08
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Attenuated feline rhinotracheitis herpesvirus,Inactivated feline Calicivirosis antigens
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial Laboratory of Lyon Porte des Alpes, Francija
|
| Date of authorisation/renewal: |
15-Jan-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/051/001 |
|
10 |
Stikla pudelīte, 1 deva |
-
|
|
|
BioBos Respi 2 intranasal
|
-
|
V/I/25/0035
|
Bioveta, a.s., Čehija
|
QI02AD07
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
nasal spray, lyophilisate and solvent for suspension
|
| International name (active substance): |
Live attenuated Bovine parainfluenza type 3 virus, strain Bio 23/A, Live attenuated Bovine respiratory syncytial virus, strain Bio 24/A
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
27-May-2025
|
| Marketing authorisation valid until: |
26-May-2030
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 27052025LI (09-Dec-2025)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/25/0035-01 |
|
1 |
Stikla flakons, 5 deva |
[PDF]
[PDF]
|
|
|
NASYM
|
-
|
EU/2/19/241/002
|
Laboratorios Hipra S.A., Spānija
|
QI02AD04
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Lyophilisate and solvent for suspension for injection or nasal spray
|
| International name (active substance): |
Live attenuated bovine respiratory syncytial virus, strain Lym-56
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
29-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/241/002 |
|
1 |
Stikla flakons, 25 devas/flakonā |
-
|
|
|
Purevax RCPCh FeLV
|
-
|
EU/2/04/047/001
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI06AJ03
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Attenuated feline rhinotracheitis herpesvirus,Live attenuated feline panleucopenia virus,Attenuated Chlamydophila felis,Inactivated feline Calicivirosis antigens
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial Laboratory of Lyon Porte des Alpes, Francija
|
| Date of authorisation/renewal: |
23-Feb-2005
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/047/001 |
1 devas/flakonā |
10 |
Stikla pudelīte, 1 deva |
-
|
|
|
Metacam
|
5 mg/ml
|
EU/2/97/004/036
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Labiana Life Sciences S.A., Spānija
|
| Date of authorisation/renewal: |
06-Dec-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/004/036 |
5 mg/ml |
12 |
Flakons, 20 ml |
-
|
|
|
FATROVAX RHD
|
-
|
EU/2/21/275/002
|
Fatro S.p.A., Itālija
|
QI08AA01
|
rabbits
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Rabbit hemorrhagic disease virus VP1A, Rabbit hemorrhagic disease virus 2 VP1AB
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Fatro S.p.A., Itālija
|
| Date of authorisation/renewal: |
16-Aug-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/275/002 |
|
1 |
Polipropilēna flakons, 50 deva |
-
|
|
|
Cerenia
|
24 mg
|
EU/2/06/062/002
|
Zoetis Belgium S.A., Beļģija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Maropitant citrate monohydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer PGM, Francija
|
| Date of authorisation/renewal: |
29-Sep-2006
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/062/002 |
24 mg |
4 |
Alumīnija blisteris, 1 tablete |
-
|
|
|
Numelvi
|
21.6 mg
|
EU/2/25/351/006
|
Intervet International B.V., Nīderlande
|
QD11AH93
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Atinvicitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
24-Jul-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/351/006 |
21,6 mg/tabl. |
3 |
Blisteris, 30 tablete |
-
|
|
|
EVANT
|
-
|
EU/2/18/223/003
|
Laboratorios Hipra S.A., Spānija
|
QI01AN01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension and solvent for oral spray
|
| International name (active substance): |
Eimeria acervulina, strain 003, Eimeria maxima, strain 013, Eimeria mitis, strain 006, Eimeria praecox, strain 007, Eimeria tenella, strain 004
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
05-Feb-2019
|
| Marketing authorisation valid until: |
04-Feb-2024
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/223/003 |
|
1 |
Stikla flakons un flakons, 10000 deva |
-
|
|
|
Purevax RCP
|
-
|
EU/2/04/052/001
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI06AH09
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Attenuated feline rhinotracheitis herpesvirus,Live attenuated feline panleucopenia virus,Inactivated feline Calicivirosis antigens
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial Laboratory of Lyon Porte des Alpes, Francija
|
| Date of authorisation/renewal: |
25-Jan-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/052/001 |
1 devas/flakonā |
10 |
Stikla pudelīte, 1 deva |
-
|
|
|
Tulissin
|
25 mg/ml
|
EU/2/20/252/011
|
VIRBAC, Francija
|
QJ01FA94
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
FAREVA AMBOISE, Francija;VIRBAC, Francija
|
| Date of authorisation/renewal: |
24-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/252/011 |
25 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
|
|
Suiseng Diff/A
|
-
|
EU/2/21/278/005
|
Laboratorios Hipra S.A., Spānija
|
QI09AB12
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Clostridioides difficile, toxoid A (TcdA), Clostridioides difficile, toxoid B (TcdB), Clostridium perfringens type A, α-toxoid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
07-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/278/005 |
|
1 |
PET flakons, 100 ml/50 deva |
-
|
|
|
Bravecto
|
150 mg/ml
|
EU/2/13/158/035
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
powder and solvent for suspension for injection
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet UK Ltd, Lielbritānija
|
| Date of authorisation/renewal: |
11-Feb-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/035 |
|
10 |
I tipa stikla flakons, 2,51 g |
-
|
|
|
UBAC
|
deva
|
EU/2/18/227/002
|
Laboratorios Hipra S.A., Spānija
|
QI02AB
|
cattle (calf)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Streptococcus uberis
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
26-May-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/227/002 |
5 deva |
1 |
PET pudele, 10 ml |
-
|
|
|
Improvac
|
-
|
EU/2/09/095/002
|
Zoetis Belgium S.A., Beļģija
|
QG03XA91
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Gonadorelin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Animal Health s.a., Beļģija
|
| Date of authorisation/renewal: |
10-Apr-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/095/002 |
|
10 |
Polietilēna pudele, 100 ml |
-
|
|